Frederick Health Offers New Targeted Cancer Therapy

Frederick Health is now providing FDA-approved radioligand therapy to cancer patients in western Maryland.

Updated on Oct. 28, 2026 in Cancer

Frederick Health Offers New Targeted Cancer Therapy

Live Poll

Do you feel local hospitals in your community offer the latest medical breakthroughs when needed?

Frederick Health has introduced radioligand therapy, an FDA-approved treatment that uses targeted radiation to attack cancer cells. This advanced procedure is now available to patients throughout western Maryland.

Why it matters

This introduction brings specialized cancer care to the local community, allowing patients in the region to access innovative, targeted radiation treatments closer to home.

The introduction of this therapy follows 20 years of research and clinical development into targeted radioligand applications. The treatment is delivered to patients through an intravenous procedure.

The players

Frederick Health

This health system serves as the primary medical provider for residents of Frederick and western Maryland.

The details

The therapy delivers precise radiation directly to cancer cells while minimizing impact on surrounding tissue. Following the intravenous administration, patients are discharged from the hospital immediately, though they must adhere to specific safety precautions afterward.

Scientists spent the past 20 years perfecting radioligand therapy.
Frederick Health officially introduced the therapy on October 28, 2026.

Health Landscape

The introduction of this treatment marks a significant expansion of precision medicine under the FDA drug and therapy approval process. It follows a multi-decade trajectory of refining targeted radiation techniques to improve patient outcomes.

Patients receiving this therapy can expect to return home immediately following the intravenous procedure. Individuals should consult with their healthcare providers to understand the specific safety precautions required after discharge.

The takeaway

Radioligand therapy represents a move toward more precise, targeted oncology treatments. Residents should speak with their oncologists to determine if this new local option aligns with their individual treatment plans.